Page last updated: 2024-12-08

arabinose 5-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arabinose 5-phosphate: RN given refers to (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-arabinose 5-phosphate : An arabinose phosphate that is D-arabinose having a phosphate substituent at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

aldehydo-D-arabinose 5-phosphate : The 5-phospho derivative of D-arabinose. It is an intermediate in the synthesis of lipopolysaccharides. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID188324
CHEMBL ID1162524
CHEBI ID16241
SCHEMBL ID939515
MeSH IDM0090696

Synonyms (21)

Synonym
d-arabinose 5-(dihydrogen phosphate)
d-a-5-p
CHEBI:16241 ,
5-o-phosphono-d-arabinose
a5p ,
13137-52-5
aldehydo-d-arabinose 5-phosphate
d-arabinose 5-phosphate
ARABINOSE-5P ,
C01112
1UJ6
CHEMBL1162524
[(2r,3r,4s)-2,3,4-trihydroxy-5-oxopentyl] dihydrogen phosphate
arabinose 5-phosphate
d-arabinose, 5-(dihydrogen phosphate)
SCHEMBL939515
{[(2r,3r,4s)-2,3,4-trihydroxy-5-oxopentyl]oxy}phosphonic acid
arabinose-5-p
DTXSID90927171
Q27101812
PD193841
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
D-arabinose 5-phosphateAn arabinose phosphate that is D-arabinose having a phosphate substituent at position 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Lipopolysaccharide Biosynthesis4153
Lipopolysaccharide Biosynthesis II4053
Lipopolysaccharide Biosynthesis III3352
CMP-3-Deoxy-D-Manno-Octulosonate (CMP-Kdo) Biosynthesis411
GDP-arabinose biosynthesis08
CMP-KDO biosynthesis I010
CMP-3-deoxy-D-manno-octulosonate biosynthesis29

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, ribose 5-phosphate isomeraseThermus thermophilusKi890.0000890.0000890.0000890.0000AID977610
Chain A, ribose 5-phosphate isomeraseThermus thermophilusKi890.0000890.0000890.0000890.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID390269Activity at Neisseria meningitidis B MC58 (ATCC BAA355) recombinant 3-deoxy-D-manno-octulosonate 8-phosphate synthase expressed in Escherichia coli BL21 (DE3)2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Arabinose 5-phosphate analogues as mechanistic probes for Neisseria meningitidis 3-deoxy-D-manno-octulosonate 8-phosphate synthase.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2003The Journal of biological chemistry, Dec-05, Volume: 278, Issue:49
Oxyanion hole-stabilized stereospecific isomerization in ribose-5-phosphate isomerase (Rpi).
AID1811Experimentally measured binding affinity data derived from PDB2003The Journal of biological chemistry, Dec-05, Volume: 278, Issue:49
Oxyanion hole-stabilized stereospecific isomerization in ribose-5-phosphate isomerase (Rpi).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (21.95)18.7374
1990's6 (14.63)18.2507
2000's18 (43.90)29.6817
2010's7 (17.07)24.3611
2020's1 (2.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.40 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (97.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]